In 2016, the Enzyme-Linked Immunosorbent Assay (ELISA) market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.
In United States market, the top players include
- R&D Systems
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BD Biosciences
- ZEUS Scientific
- Bio-Rad Laboratories
- ALPCO
- Enzo Life Sciences
- BioMérieux
- EMD Millipore
- BioLegend
- LOEWE Biochemica
- Mercodia
- Cusabio
- Shanghai Kehua Bio-engineering
Split by product types/category, covering
- Sandwich ELISA
- Indirect ELISA
- Competitive ELISA
- Others
Split by applications/end use industries, covers
- Immunology
- Inflammation
- Infectious Diseases
- Cancer
- Protein Quantitation
- Others